These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26072406)

  • 1. Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors.
    Jaschinski F; Korhonen H; Janicot M
    Methods Mol Biol; 2015; 1317():137-51. PubMed ID: 26072406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Role and Therapeutic Targeting of TGF-β
    Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
    Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
    Makhijani NS; Bischoff DS; Yamaguchi DT
    J Cell Physiol; 2005 Jan; 202(1):304-13. PubMed ID: 15389595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
    Nilsson EE; Doraiswamy V; Skinner MK
    Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.
    Jeong HS; Park KK; Park KK; Kim SP; Choi IJ; Lee IK; Kim HC
    J Korean Med Sci; 2004 Jun; 19(3):374-83. PubMed ID: 15201503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
    Marzo AL; Fitzpatrick DR; Robinson BW; Scott B
    Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides.
    Shen ZJ; Kim SK; Kwon OS; Lee YS; Moon BJ
    Eur J Biochem; 2001 Apr; 268(8):2331-7. PubMed ID: 11298751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.
    Tzai TS; Lin CI; Shiau AL; Wu CL
    Anticancer Res; 1998; 18(3A):1585-9. PubMed ID: 9673374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages.
    Jun CD; Choi BM; Kim SU; Lee SY; Kim HM; Chung HT
    Immunology; 1995 May; 85(1):114-9. PubMed ID: 7635512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
    Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
    Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
    Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
    Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.
    Cordeiro MF; Mead A; Ali RR; Alexander RA; Murray S; Chen C; York-Defalco C; Dean NM; Schultz GS; Khaw PT
    Gene Ther; 2003 Jan; 10(1):59-71. PubMed ID: 12525838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
    Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
    Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides.
    Jachimczak P; Fabel-Schulte K; Hessdörfer B; Brysch W; Schlingensiepen KH; Blesch A; Bogdahn U
    Cell Immunol; 1995 Oct; 165(1):125-33. PubMed ID: 7671316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages.
    Huber-Ruano I; Raventós C; Cuartas I; Sánchez-Jaro C; Arias A; Parra JL; Wosikowski K; Janicot M; Seoane J
    Ann Oncol; 2017 Sep; 28(9):2278-2285. PubMed ID: 28911087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.